Peringatan Keamanan

The following adverse events were most common (>10%) when mesna was administered with ifosfamide: nausea, vomiting, fatigue, fever, abdominal pain, constipation, diarrhea, leukopenia, anorexia, thrombocytopenia, anemia, granulocytopenia, asthenia, headache, alopecia, and somnolence. Hypersensitivity reactions and dermatologic toxicity may occur in patients taking mesna; therefore, if either reaction occurs, mesna should be discontinued and patient should be provided with supportive care.

Coenzyme M

DB09110

small molecule approved investigational

Deskripsi

Coenzyme M (commonly known by its salt form, Mesna) is a synthetic sulfhydryl (thiol) compound and is used for prophylaxis of Ifosfamide and cyclophosphamide induced hemorrhagic cystitis.A18572

Struktur Molekul 2D

Berat 142.197
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) The elimination half-life is 0.36 hours for mesna and 1.17 hours for dimesna.
Volume Distribusi Vd = 0.652 ± 0.242 L/Kg after intravenous administration of mesna.
Klirens (Clearance) Plasma clearance of mesna = 1.23 L/h/kg

Absorpsi

Peak plasma concentrations were reached within 1.5-4 hours for free mesna, and 3-7 hours for total mesna following oral administration. The average oral bioavailability is 58% for free mesna and 89% for total mesna. Food has no effect on the urinary availability of mesna.

Metabolisme

Mesna undergoes rapid oxidation to mesna disulfide (dimesna) which is its major metabolite.

Rute Eliminasi

Within 24 hours, approximately 32% of administered dose is eliminated in the urine as mesna while 33% is eliminated as dimesna.

Interaksi Makanan

1 Data
  • 1. No food interactions are expected.

Interaksi Obat

0 Data
Tidak ada data.

Referensi & Sumber

Artikel (PubMed)
  • PMID: 27566144
    Matz EL, Hsieh MH: Review of Advances in Uroprotective Agents for Cyclophosphamide and Ifosfamide-Induced Hemorrhagic Cystitis. Urology. 2016 Aug 23. pii: S0090-4295(16)30458-7. doi: 10.1016/j.urology.2016.07.030.
  • PMID: 21505084
    Cutler MJ, Urquhart BL, Velenosi TJ, Meyer Zu Schwabedissen HE, Dresser GK, Leake BF, Tirona RG, Kim RB, Freeman DJ: In vitro and in vivo assessment of renal drug transporters in the disposition of mesna and dimesna. J Clin Pharmacol. 2012 Apr;52(4):530-42. doi: 10.1177/0091270011400414. Epub 2011 Apr 19.
Link

Contoh Produk & Brand

Produk: 31 • International brands: 2
Produk
  • IFEX and MESNEX
    Kit • - • Intravenous • US • Approved
  • IFEX and MESNEX
    Kit • - • Intravenous • US • Approved
  • IFEX and MESNEX
    Kit • - • Intravenous • US • Approved
  • Ifosfamide and Mesna
    Kit • - • Intravenous • US • Generic • Approved
  • Ifosfamide and Mesna
    Kit • - • Intravenous • US • Generic • Approved
  • Ifosfamide and Mesna
    Kit • - • Intravenous • US • Generic • Approved
  • Mesna
    Injection, solution • 100 mg/1mL • Intravenous • US • Generic • Approved
  • Mesna
    Injection, solution • 100 mg/1mL • Intravenous • US • Generic • Approved
Menampilkan 8 dari 31 produk.
International Brands
  • Mistabron
  • Mistabronco

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul